ITCC - Innovative Therapies for Children with Cancer in Europe

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC LOXO Biology Post-Doctoral Fellowship Program

ITCC LOXO Biology Post-Doctoral Fello...

Replication stress checkpoint addiction in neuroblastoma: exploring mechanisms and therapeutic opportunities

Learn More

ITCC & Industry


  • ensure that industry development programs meet science and patients’ needs by being part of the prioritization processes and discussions,
  • facilitate the implementation of industry trials across the ITCC network and thus increase the number of ITCC labeled industry trials in Europe
  • facilitate access to compounds for the development of innovative academic combination trials that will be fit for filing and for basic and translational research conducted within ITCC
Learn more

Innovative Therapies for Children with Cancer

The Innovative Therapies for Children with Cancer (ITCC) Consortium was created in 2003. It is a non profit organisation under the French Law.

ITCC gathers 63 European Paediatric Oncology Departments with expertise in conducting early phase trials in children and adolescents, and 25 European research laboratories.

The aim of this organisation is to develop novel therapies for the treatment of paediatric and adolescent cancers in cooperation with regulatory bodies, pharmaceutical enterprises, parents and patients.


In January 2011 ITCC was established as a European Category 1 Network for Paediatric Research at the European Medicines Agency (EnprEMA).


Its structure comprises several Committees which take care and contribute to a particular issue in the development of novel therapeutic strategies in paediatric oncology.

Special partners